Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

First direct KRAS G12V(ON) inhibitors developed at Revolution Medicines

May 4, 2021

FDA approves IND for KRAS G12C inhibitor JAB-21822

May 4, 2021

Repare initiates phase I trial of oral PKMYT1 inhibitor RP-6306

May 3, 2021

Monte Rosa Therapeutics discloses new protein cereblon modulators

May 3, 2021

Patient dosing begins in phase Ib/II study of CFI-400945 in leukemia

May 3, 2021

A different path to specificity for Ras inhibitors

May 3, 2021

Phase IIb/III study of masitinib in metastatic CRPC meets primary endpoint

April 30, 2021

PRT-1419 shows potent antitumor activity in preclinical models

April 30, 2021

First-in-class KAT6A/KAT6B inhibitor PF-9363 shows antitumor activity against ER+ breast cancer

April 30, 2021

Goldfinch Biopharma discovers CDK5 inhibitors

April 30, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...